Cash flow quality is severely compromised, with AFFO plummeting to -$101.4M in 2025Q4 as capital expenditure intensity reached $105.1M, far outpacing recurring cash generation.
| Metric | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Aug'14 | Aug'13 | Aug'12 |
|---|
| Cash from Operations | 73.61M | 70.05M | 68.44M | 76.54M | 68.97M | 34.52M | 36.43M | 24.83M | 11.6M | -2.72M | -208.8K | -146.26K | -33.79K | -35.11K |
| Operating CF Growth % | 5.09% | 2.35% | -10.58% | 10.98% | 99.79% | -5.24% | 46.68% | 114.03% | 526.08% | -1204.19% | -42.76% | -332.8% | 3.74% | - |
| Operating CF / Revenue % | 49.67% | 50.61% | 48.56% | 55.8% | 59.55% | 36.91% | 51.5% | 46.69% | 38.39% | -33.7% | -10.13% | -38.45% | - | - |
| Net Income | -6.88M | 6.63M | 20.61M | 20M | 18.34M | -2.5M | 9.59M | 14.56M | -87K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
| Depreciation & Amortization | 58.04M | 56.08M | 59.01M | 57.66M | 47.31M | 36.82M | 25.52M | 17.96M | 10.13M | 2.38M | 659.67K | 129.08K | 0 | 0 |
| Stock-Based Compensation | 4.5M | 5.1M | 4.24M | 4.68M | 5.81M | 5.32M | 3.34M | 2.67M | 1.8M | 1.68M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 17.95M | 1.01M | -9.73M | -4.06M | 1.33M | 1.56M | 1.76M | 1.75M | 1.48M | 350.44K | 126.53K | 26.44K | 11.54K | 15K |
| Working Capital Changes | 0 | 1.21M | -5.69M | -1.74M | -3.82M | -7.65M | -3.77M | -4.43M | -1.71M | -780.96K | 614.24K | 350.42K | 11.54K | 15K |
| Cash from Investing | -60.4M | -45.94M | 67.62M | -137.25M | -194.66M | -223.67M | -258.2M | -151.62M | -252.65M | -150.36M | -32.34M | -21.88M | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 | -5.09M | 0 | 0 | 0 | -140.37K | 0 | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | -2.78M | -1.54M | 0 | -373K | -426K | -797.82K | -385.1K | 0 | 0 | 0 |
| Sale of Investments | 21.47M | 57.62M | 0 | 0 | 0 | 208K | 0 | 23.95M | 21K | 242.04K | 0 | 0 | 0 | 0 |
| Other Investing | -81.87M | -103.56M | 67.62M | 13.68M | 366K | 1.54M | -3.21M | 5.26M | -433K | 242.04K | -32.34M | -14.94K | 0 | 0 |
| Cash from Financing | -10.26M | -21.89M | -143.79M | 62.41M | 127.7M | 192.72M | 224.11M | 124.51M | 226.49M | 163.57M | 41.64M | 22.19M | 25K | 0 |
| Dividends Paid | -52.31M | -65.69M | -64.85M | -64.24M | -58.32M | -45.77M | -34.99M | -24.79M | -15.98M | -3.88M | -255.6K | -42.62K | 0 | 0 |
| Common Dividends | 0 | -59.87M | -59.02M | -58.42M | -52.5M | -39.94M | -29.17M | -18.96M | -15.23M | -3.88M | -256K | -42.62K | 0 | 0 |
| Debt Issuance (Net) | 0 | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Share Repurchases | -6M | 0 | 0 | 0 | 0 | 0 | 0 | -263K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 42.05M | 252K | 7.15M | -5.19M | -8.89M | -2.83M | -1.33M | -3.1M | -3.06M | -2.9M | -389.14K | 19.58M | 0 | 0 |
| Net Change in Cash | 2.95M | 2.22M | -7.73M | 1.7M | 2.01M | 3.57M | 2.34M | -2.27M | -14.56M | 10.49M | 9.1M | 159.47K | -8.79K | -35.11K |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 8.94M | 6.72M | 14.46M | 12.76M | 10.75M | 7.18M | 4.84M | 7.11M | 19.67M | 9.18M | 88.81K | 3.52K | 12.31K | 47.42K |
| Cash at End | 11.89M | 8.94M | 6.72M | 14.46M | 12.76M | 10.75M | 7.18M | 4.84M | 5.11M | 19.67M | 9.18M | 162.99K | 3.52K | 12.31K |
| Free Cash Flow | 73.61M | -25.07M | 58.39M | -79.66M | -132.69M | -184.27M | -220.38M | -156M | -240.62M | -153.18M | -32.41M | -22.01M | -33.79K | -35.11K |
| FCF Growth % | 393.58% | -142.94% | 173.3% | 39.97% | 27.99% | 16.39% | -41.27% | 35.17% | -57.08% | -372.6% | -47.24% | -65039.74% | 3.74% | - |
| FCF / Revenue % | 49.67% | -18.12% | 41.43% | -58.08% | -114.58% | -197.04% | -311.6% | -293.28% | -796.14% | -1895.93% | -1572.15% | -5786.81% | - | - |
Unsustainable dividend payout coverage
According to the company's quarterly financial disclosures, the dividend payout ratio relative to AFFO reached an alarming 414% in 2025Q4, indicating that the current distribution is not supported by recurring cash flow and may necessitate a strategic re-evaluation of the company's capital return policy.
The persistent negative AFFO figures suggest that the REIT is currently unable to fund its dividend from operations after accounting for necessary maintenance capital and leasing costs. Investors should monitor whether management continues to utilize external financing to bridge this widening gap, as such reliance on debt or equity issuance to fund distributions is rarely sustainable over the long term.
As reported in recent SEC filings, the divergence between GAAP net income and FFO highlights a significant distortion, with FFO/NI ratios reaching -1.84 in 2025Q4, suggesting that non-cash accounting charges are failing to capture the true economic reality of the company's deteriorating cash-generating capacity.
While REITs typically use FFO to normalize for depreciation, the extreme volatility in this metric for GMRE implies that the underlying asset performance is being obscured by accounting adjustments. This disconnect warrants further investigation into whether the reported FFO is truly representative of the cash available to shareholders or if it is being inflated by non-recurring items.
Based on the provided financial statements, capital expenditures surged to -$105.1M in 2025Q4, a substantial increase that appears to be placing immense pressure on the company's liquidity and further distancing the firm from achieving a self-funding status for its property-level maintenance and tenant improvement requirements.
The significant spike in capital outflows suggests that the portfolio may require more intensive reinvestment than previously anticipated, potentially due to aging facilities or competitive pressures to retain tenants. This level of spending appears to be a primary driver of the negative AFFO, raising questions about the long-term yield profile of the existing asset base.
Financial data indicates that while GAAP operating cash flow remained positive at $21.6M in 2025Q4, the quality of these earnings is questionable when contrasted with the massive capital expenditure requirements that effectively negate the REIT's ability to generate meaningful free cash flow for its investors.
The reliance on operating cash flow to cover both massive capex and dividend payments appears increasingly precarious given the current trajectory. Analysts should monitor whether the company's operational cash generation can stabilize without further dilutive financing, as the current trend suggests a structural mismatch between cash inflows and the capital intensity of the portfolio.
Quick answers to the most common questions about buying GMRE stock.
Global Medical REIT Inc. (GMRE) generated $73.6M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Global Medical REIT Inc. (GMRE) generated $73.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Global Medical REIT Inc. (GMRE) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Global Medical REIT Inc. (GMRE) returned $52.3M to shareholders via cash dividends and spent $6.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.